Risk Minimization Guidance Trio Focus On All Aspects Of Drug Development
Findings from actual use trials on OTC drugs may be helpful in reducing the risk of medication errors, FDA says in a final guidance on FDL-1Premarketing Risk Assessment
Findings from actual use trials on OTC drugs may be helpful in reducing the risk of medication errors, FDA says in a final guidance on FDL-1Premarketing Risk Assessment